(Q53909174)

English

Factors influencing pain outcome in herpes zoster: an observational study with valaciclovir. Valaciclovir International Zoster Assessment Group (VIZA).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10877249

Factors influencing pain outcome in herpes zoster: an observational study with valaciclovir. Valaciclovir International Zoster Assessment Group (VIZA). (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10877249

1 reference

based on heuristic

inferred from title

author name string

Decroix J

1

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10877249

Partsch H

2

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10877249

Gonzalez R

3

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10877249

Mobacken H

4

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10877249

Goh CL

5

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10877249

Walsh L

6

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10877249

Shukla S

7

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10877249

Naisbett B

8

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10877249

publication date

1 January 2000

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10877249

Journal of the European Academy of Dermatology and Venereology

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10877249

14

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10877249

1

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10877249

23-33

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10877249

Varicella and herpes zoster. Changing concepts of the natural history, control, and importance of a not-so-benign virus

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2000.00020.X

21 January 2018

Selective decline in cellular immune response to varicella-zoster in the elderly

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2000.00020.X

21 January 2018

The natural history of herpes zoster

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2000.00020.X

21 January 2018

Management of ophthalmic zoster

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2000.00020.X

21 January 2018

Natural history of herpes zoster ophthalmicus: predictors of postherpetic neuralgia and ocular involvement

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2000.00020.X

21 January 2018

Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2000.00020.X

21 January 2018

Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2000.00020.X

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2000.00020.X

21 January 2018

Acute herpetic and postherpetic neuralgia: clinical review and current management

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2000.00020.X

21 January 2018

A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2000.00020.X

21 January 2018

Treatment of Herpes zoster with Idoxuridine Ointment, Including a Multivariate Analysis of Symptoms and Signs

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2000.00020.X

21 January 2018

Famciclovir for the Treatment of Acute Herpes Zoster: Effects on Acute Disease and Postherpetic Neuralgia: A Randomized, Double-Blind, Placebo-Controlled Trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2000.00020.X

21 January 2018

Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.2000.00020.X

21 January 2018

Identifiers

10.1046/J.1468-3083.2000.00020.X

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10877249

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10877249

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53909174&oldid=2004547098"